At the 2025 Guangdong-Hong Kong-Macao Greater Bay Area High-Value Intellectual Property Cultivation and Layout Competition, Muen (Guangzhou) Biotechnology Co., Ltd. distinguished itself from 1,558 competing teams to secure the Silver Award for its ‘Next-Generation Innovative Microecological Preparations R&D and Industrialisation Project’. This accolade not only signifies authoritative recognition of Muen Bio’s comprehensive capabilities in technological innovation and intellectual property strategy but also sends a clear signal: within the globally pioneering field of second-generation probiotics, Chinese innovation is seizing critical strategic high ground through foundational research strengths. The project’s core highlight—Akkermansia muciniphila (AKM Lab-01®)—has set new benchmarks for the industry by achieving three pharmaceutical-grade innovations that elevate the standards for probiotic formulations.